[Exogenic photodermatoses (author's transl)].
D010129:4-Aminobenzoic Acid / Q000009:adverse effects; D004396:Coloring Agents / Q000009:adverse effects; D011564:Furocoumarins / Q000009:adverse effects; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D010640:Phenothiazines / Q000009:adverse effects; D010787:Photosensitivity Disorders / Q000209:etiology*; D010859:Pigmentation Disorders / Q000188:drug therapy; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D012458:Salicylanilides / Q000009:adverse effects; D012871:Skin Diseases / Q000209:etiology*; D013267:Stilbenes / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013638:Tars / Q000009:adverse effects; D014212:Tretinoin / Q000627:therapeutic use; D014466:Ultraviolet Rays / Q000009:adverse effects
D004396:Coloring Agents; D011564:Furocoumarins; D006873:Hydroquinones; D010640:Phenothiazines; D011837:Radiation-Protective Agents; D012458:Salicylanilides; D013267:Stilbenes; D013449:Sulfonamides; D013638:Tars; D014212:Tretinoin; D010129:4-Aminobenzoic Acid
Exogene Photodermatosen.